[DPHARMA] YoY TTM Result on 31-Mar-2009 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
26-May-2009
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2009
Quarter
31-Mar-2009 [#1]
Profit Trend
QoQ- -1.22%
YoY- -13.87%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
Revenue 141,205 135,625 124,896 123,065 114,918 105,791 99,506 6.00%
PBT 35,723 36,493 35,638 34,863 41,521 38,499 36,450 -0.33%
Tax -8,233 -7,030 -7,252 -7,795 -10,093 -9,211 -11,220 -5.02%
NP 27,490 29,463 28,386 27,068 31,428 29,288 25,230 1.43%
-
NP to SH 27,490 29,463 28,386 27,068 31,428 29,288 25,230 1.43%
-
Tax Rate 23.05% 19.26% 20.35% 22.36% 24.31% 23.93% 30.78% -
Total Cost 113,715 106,162 96,510 95,997 83,490 76,503 74,276 7.34%
-
Net Worth 170,824 162,320 146,967 137,340 120,710 152,576 147,741 2.44%
Dividend
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
Div 24,987 6,402 16,743 20,833 47,174 29,860 24,398 0.39%
Div Payout % 90.90% 21.73% 58.98% 76.97% 150.11% 101.95% 96.70% -
Equity
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
Net Worth 170,824 162,320 146,967 137,340 120,710 152,576 147,741 2.44%
NOSH 138,881 138,735 138,648 138,727 138,747 138,706 139,378 -0.05%
Ratio Analysis
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
NP Margin 19.47% 21.72% 22.73% 21.99% 27.35% 27.68% 25.36% -
ROE 16.09% 18.15% 19.31% 19.71% 26.04% 19.20% 17.08% -
Per Share
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
RPS 101.67 97.76 90.08 88.71 82.83 76.27 71.39 6.06%
EPS 19.79 21.24 20.47 19.51 22.65 21.12 18.10 1.49%
DPS 18.00 4.61 12.06 15.00 34.00 21.50 17.50 0.47%
NAPS 1.23 1.17 1.06 0.99 0.87 1.10 1.06 2.50%
Adjusted Per Share Value based on latest NOSH - 138,727
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
RPS 14.68 14.10 12.98 12.79 11.95 11.00 10.34 6.00%
EPS 2.86 3.06 2.95 2.81 3.27 3.04 2.62 1.47%
DPS 2.60 0.67 1.74 2.17 4.90 3.10 2.54 0.38%
NAPS 0.1776 0.1687 0.1528 0.1428 0.1255 0.1586 0.1536 2.44%
Price Multiplier on Financial Quarter End Date
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
Date 30/03/12 31/03/11 31/03/10 31/03/09 31/03/08 30/03/07 31/03/06 -
Price 2.40 2.35 2.40 2.10 2.60 2.60 2.65 -
P/RPS 2.36 2.40 2.66 2.37 3.14 3.41 3.71 -7.25%
P/EPS 12.13 11.07 11.72 10.76 11.48 12.31 14.64 -3.08%
EY 8.25 9.04 8.53 9.29 8.71 8.12 6.83 3.19%
DY 7.50 1.96 5.03 7.14 13.08 8.27 6.61 2.12%
P/NAPS 1.95 2.01 2.26 2.12 2.99 2.36 2.50 -4.05%
Price Multiplier on Announcement Date
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
Date 17/05/12 25/05/11 25/05/10 26/05/09 21/05/08 21/05/07 18/05/06 -
Price 2.38 2.57 2.38 2.34 2.55 2.78 2.67 -
P/RPS 2.34 2.63 2.64 2.64 3.08 3.64 3.74 -7.51%
P/EPS 12.02 12.10 11.62 11.99 11.26 13.17 14.75 -3.35%
EY 8.32 8.26 8.60 8.34 8.88 7.60 6.78 3.46%
DY 7.56 1.79 5.07 6.41 13.33 7.73 6.56 2.39%
P/NAPS 1.93 2.20 2.25 2.36 2.93 2.53 2.52 -4.34%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment